Editorial policy
About this desk
glp1ranked.com publishes independent rankings and buying guides for FDA-approved GLP-1 and dual GIP/GLP-1 medicines, telehealth access paths, and pharmacies.
What we own, and what we don’t
This site covers compare, price, and rank. Living with these medicines — side effects, habits, protein, travel, missed-dose routines — belongs to our sister site,glp1userguide.com. We link out instead of rewriting that desk.
The audience is adults researching FDA-approved options, cash pay versus insurance, and telehealth access. We are not writing continuing education for clinicians, and we are not a clinic.
Independence
- Scores and rankings are not for sale. There is no pay-for-placement.
- We do not accept payment to recommend illegal or unsafe drug sources.
- Display-ad slots are reserved and labeled. No ad network code runs on the site today.
- If affiliate links are added later, they will be limited to branded manufacturer programs, licensed telehealth that dispenses FDA-approved medicines, and major pharmacies. Payment will not change a score.
- A commercial relationship we know about is disclosed. If we do not know, we say unconfirmed.
The scoring rules are public on the methodology page. The money rules are public on the affiliate disclosure.
How a page gets edited
- Headlines are sentence case, with the drug or job of the page first. No clickbait questions.
- A price or health claim links a primary source: a manufacturer page, an FDA label, or a peer-reviewed paper.
- We summarize sources. We do not paste full labels or articles. Short quotes are attributed.
- Rankings show an updated date. Prices show an as-of date.
- We do not shame body size, food, or the decision to use a medication.
- We do not use miracle language, before-and-after body photos, or sensational nicknames for side effects.
- Trademarks are used descriptively. We do not use pharma logos or imply a company endorses this site.
What we will not publish
- Rankings or affiliate links for illegal compounded products, research peptides, or overseas gray-market sellers.
- Personalized dosing, or any line that tells a reader to start, stop, or switch a medicine.
- A suggestion that a compounded product is the generic of an FDA-approved drug.
- AI-generated photos of “patients,” or before-and-after bodies.
Corrections
Email editorial@glp1ranked.com with the page URL, the sentence, and the source you think is right. The contact page lists what to include. We would rather correct a price than win an argument about a stale one.
Health boundaries for every page are spelled out in the medical disclaimer. These products’ labels include a boxed warning about thyroid C-cell tumors. A clinician who knows the reader is the person who decides whether a treatment fits.